Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12054549
APP PUB NO 20230322934A1
SERIAL NO

18050817

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-αv integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK KGAAFRANKFURTER STRASSE 250 DARMSTADT 64293

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bender, Andrew Reading, US 5 2
Celik, Ilhan Zwingenberg, DE 9 5
Raab-Westphal, Sabine Rosbach, DE 2 0
Samy, Eileen Arlington, US 4 16
Staub, Eike Darmstadt, DE 10 8
Urban, Miriam Leidersbach, DE 3 2
Varrone, Georgianna Tewksbury, US 1 0
Wu, Yin Andover, US 19 95
Xu, Daigen Westford, US 10 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 6, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 6, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 6, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00